serw-MX  [xml]  

 DeCS Categories

D04 Polycyclic Compounds .
D04.345 Macrocyclic Compounds .
D04.345.566 Peptides, Cyclic .
D04.345.566.802 Streptogramins .
D04.345.566.802.875 Virginiamycin .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.641 Peptides, Cyclic .
D12.644.641.802 Streptogramins .
D12.644.641.802.875 Virginiamycin .
G05 Genetic Phenomena .
G05.285 Founder Effect .
HP1 Homeopathy .
HP1.007 Homeopathic Philosophy .
HP1.007.148 Homeopathy Foundation .
N02 Health Care Facilities, Manpower, and Services .
N02.421 Health Services .
N02.421.911 Tissue and Organ Procurement .
N03 Health Care Economics and Organizations .
N03.219 Economics .
N03.219.483 Financial Support .
N03.219.483.311 Foundations .
N03.540 Organizations .
N03.540.630 Organizations, Nonprofit .
N03.540.630.180 Foundations .
SH1 Health Sciences, Technology and Innovation Management .
SH1.010 Policies and Cooperation in Science, Technology and Innovation .
SH1.010.020 International Cooperation .
SH1.010.020.030 Regional Agencies .
SH1. Organization of American States .
SP4 Environmental Health .
SP4.011 Science .
SP4.011.087 Contamination .
SP4.011.087.718 Industrial Pollution .
SP4.011.087.718.439 Industry .
SP4.011.087.718.439.115 Foundry .
SP4.011.122 Engineering .
SP4.011.122.403 Civil Engineering .
SP4.011.122.403.564 Construction .
SP4.011.122.403.564.770 Foundations (Soil Engineering) .
SP4.046 Occupational Health .
SP4.046.462 Industry .
SP4.046.462.798 Foundry .
VS2 Health Surveillance of Products .
VS2.003 Control and Sanitary Supervision of Cosmetics .
VS2.003.001 Cosmetics .
VS2.003.001.001 Beauty Products .
VS2. Beauty Lotions .
 Synonyms & Historicals
Foundations .
Foundation .
Organizations established by endowments with provision for future maintenance. .
Homeopathy Foundation .
Homeopathic Doctrine .
Homeopathy Basis .
Principles defining the fundamental concepts of Homeopathy: Similia, Experiments on healthy human beings, Diluted and potentized substances, Administration of one remedy at a time. .
Foundry .
Beauty Lotions .
Beauty Creams .
Milky, Creamy and Astringent Solutions .
Hand Lotions .
Foundation Makeup .
Products designed to clean, protect and refresh the skin, presented in liquid or semi-liquid form. .
Tissue and Organ Procurement .
Donor Cards .
Organ Donation .
Required Organ Donation Request .
Required Request .
Tissue Donation .
Card, Donor .
Cards, Donor .
Donor Card .
Organ Donations .
Organ Procurement System .
Organ Procurements .
Required Requests .
Tissue Donations .
Tissue Procurements .
Organ Procurement .
Tissue Procurement .
Organ Procurement Systems .
The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation. .
Foundations (Soil Engineering) .
Organization of American States .
OAS 11616 .
Panamerican Development Foundation .
PADF 11616 .
The Organization of American States (OAS) brings together the countries of the Western Hemisphere to strengthen cooperation and advance common interests. It is the region's premier forum for multilateral dialogue and concerted action. ( .
Virginiamycin .
Antibiotic 899 .
Eskalin .
Founderguard .
Stajac .
Virgimycine .
Staphylomycin .
A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry. .
Founder Effect .
Effect, Founder .
Effects, Founder .
Founder Effects .
A phenomenon that is observed when a small subgroup of a larger POPULATION establishes itself as a separate and isolated entity. The subgroup's GENE POOL carries only a fraction of the genetic diversity of the parental population resulting in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive. .